Rhumbline Advisers »

Taro Pharmaceutical Industries shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Taro Pharmaceutical Industries (TARO) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Taro Pharmaceutical Industries

Tip: Access up to 7 years of quarterly data

All positions including Taro Pharmaceutical Industries held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taro Pharmaceutical Industries by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $391k 9.4k 41.78
2023-09-30 $368k 9.8k 37.71
2023-06-30 $354k 9.3k 37.93

More positions owned by Rhumbline Advisers

Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Alphabet Inc Class C cs (GOOG)
Tesla Motors (TSLA)
Berkshire Hathaway (BRK.B)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Visa (V)
Exxon Mobil Corporation (XOM)

View all positions for Rhumbline Advisers

Top funds holding Taro Pharmaceutical Industries

Krensavage Asset Management
Dimensional Fund Advisors
Brandes Investment Partners
Vanguard Group
ARK Investment Management
Norges Bank Investment Management
Arrowstreet Capital, Limited Partnership
UBS Group
Bank of New York Mellon
Charles Schwab Investment Management
Swiss National Bank
Citadel Advisors
Barclays
Connor, Clark & Lunn Investment Management
Inspire Advisors

View all funds holding Taro Pharmaceutical Industries